Your browser doesn't support javascript.
loading
A nationwide cross-sectional survey on prevalence, management and pharmacoepidemiology patterns on hypertension in Chinese patients with chronic kidney disease.
Zhang, Wen; Shi, Wei; Liu, Zhangsuo; Gu, Yong; Chen, Qinkai; Yuan, Weijie; Zhang, Yanlin; Gong, Li; Zhou, Rong; Li, Mingxu; Cheng, Hong; Liu, Jian; Cen, Jun; Huang, Chaoxing; Ren, Yeping; Mao, Peiju; Xing, Changying; Hong, Fuyuan; Jiang, Dongsheng; Wang, Li; Xu, Gang; Liu, Jianshe; Chen, Nan.
Afiliación
  • Zhang W; Department of Nephrology, Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Shi W; Department of Nephrology, Guangdong General Hospital, Guangzhou, 510030, China.
  • Liu Z; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052 China.
  • Gu Y; Department of Nephrology, The Fifth Affiliated Hospital of Fudan University, Shanghai, 200240, China.
  • Chen Q; Department of Nephrology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China.
  • Yuan W; Department of Nephrology, The First Affiliated Hospital of Shanghai Jiao Tong University, Shanghai, 200080, China.
  • Zhang Y; Department of Nephrology, The First Affiliated Hospital of Xiamen University, Xiamen, 361003, China.
  • Gong L; Department of Nephrology, Department of Nephrology, Inner Mongolia People's Hospital, Inner Mongolia, China.
  • Zhou R; Department of Nephrology, Shanghai Yangpu Hospital, Tongji University, Shanghai, 200090, China.
  • Li M; Department of Nephrology, PLA Navy General Hospital, Beijing, 100048, China.
  • Cheng H; Department of Nephrology, Beijing Anzhen Hospital Capital Medical University, Beijing, 100029, China.
  • Liu J; Department of Nephrology, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, China.
  • Cen J; Department of Nephrology, Shanghai Construction Group Hospital, Shanghai, 200083, China.
  • Huang C; Department of Nephrology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
  • Ren Y; Department of Nephrology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Mao P; Department of Nephrology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China.
  • Xing C; Department of Nephrology, Jiangsu Province Hospital, Nanjing, 210029, China.
  • Hong F; Department of Nephrology, Fujian Provincial Hospital, Fuzhou, 350001, China.
  • Jiang D; Department of Nephrology, Jiangsu Taizhou People's Hospital, Taizhou, 225300, China.
  • Wang L; Department of Nephrology, Sichuan Provincial People's Hospital, Sichuan, 610072, China.
  • Xu G; Department of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
  • Liu J; Department of Nephrology, Union Hospital, Huazhong University of Science and Technology, Wuhan, 430022, China.
  • Chen N; Department of Nephrology, Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Sci Rep ; 6: 38768, 2016 12 20.
Article en En | MEDLINE | ID: mdl-27995959
Limited data are available on epidemiology and drug use in Chinese hypertensive patients with chronic kidney disease (CKD). We determined the prevalence; awareness, treatment, and control rates of hypertension; anti-hypertensive use, expenditure pattern; and factors associated with hypertension prevalence and control in Chinese patients with CKD. This was one of the largest cross-sectional surveys that enrolled 6079 CKD participants (mean age, 51.0 ± 16.37 years) with or without hypertension from 22 centres across China. The prevalence, awareness, and treatment rates were 71.2%, 95.4%, and 93.7%, respectively. Control rates 1 and 2 (Blood pressure, BP <140/90 and <130/80 mmHg) were 41.1% and 15.0%, respectively. Patients were treated mostly with monotherapy (37.7%) or 2-drug anti-hypertensive combination (38.7%). Factors associated with prevalence of hypertension included age; smoking; body mass index; physical exercise; family history of hypertension; hyperuricaemia; and CKD. Control rate was associated with CKD stage, BP monitoring at home, and use of drug combinations. Despite high rates of awareness and treatment, the control rates are low. CKD stages 4 and 5 adversely affect the control rate. The results suggest the immediate need of comprehensive controlling measures to improve the control of hypertension in Chinese patients with CKD.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Insuficiencia Renal Crónica / Hipertensión Renal / Antihipertensivos Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Sci Rep Año: 2016 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Insuficiencia Renal Crónica / Hipertensión Renal / Antihipertensivos Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Sci Rep Año: 2016 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido